XRP warning: Price drops 3.2% today—can surging ETF demand still push it to $4.50? Here's the full price projection
XRP price prediction
: Can XRP reach $4.50 as Teucrium ETF crosses $284M?
XRP is back under the microscope as the price flirts with the $3 mark once again. After briefly surging above $3 on July 14—for the first time since March—the token has since corrected and is trading at $2.91 as of 1:17 p.m. UTC on July 15, down 1.60% on the day.
Even with the dip, momentum remains in favor of the bulls, thanks to strong institutional demand, a bullish crossover on key moving averages, and a breakout in the XRP/ETH ratio. Investors are now watching closely to see if XRP can push to $4.50, a level supported by recent technical signals and ETF inflows.
Why did XRP price drop 3.2% today below $2.91?
XRP price slipped by 3.2% today, falling below the key $2.91 level and currently hovering around $2.87. This drop comes after XRP briefly crossed $3 for the first time since March, following a strong seven-day rally from $2.24. The pullback is largely attributed to broader market weakness and short-term profit-taking. Despite the dip, technical indicators like the 50-day and 150-day SMA convergence suggest the bullish trend isn't over yet. Analysts believe this drop could be temporary, especially with institutional demand rising through the XXRP ETF, which has now crossed $284 million in assets.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Villas For Sale in Dubai Might Surprise You
Dubai villas | search ads
Get Deals
Undo
What is supporting the XRP price prediction of $4.50?
Despite today's minor pullback, XRP still holds a bullish outlook on multiple fronts. The most important technical signal comes from the bullish convergence between the 50-day and 150-day simple moving averages (SMAs)—a classic sign that an uptrend could soon resume.
This trend is supported by the Directional Movement Index (DMI), which shows the positive DI rising while the negative DI drops, meaning buyers are still in control. The Average Directional Index (ADX) is also sloping upward, confirming the strength of the trend that recently pushed XRP from $2.24 to $3 in just seven days.
Live Events
For the bullish case to hold, however, XRP must break through the resistance zone between $3.05 and $3.16. Without a close above that area, buying pressure could stall in the short term.
Why is the XRP/ETH ratio breakout important?
Another key factor behind XRP's current momentum is the XRP/ETH ratio, which recently broke out of a two-month consolidation range, according to chart data from TradingView. When this ratio climbs, it shows XRP is outperforming Ethereum—an important signal for market strength.
This move comes alongside increasing interest from institutional investors. The Teucrium XXRP ETF, launched just four months ago, has now amassed over $284 million in assets under management. That kind of capital flow is significant, as it reflects large-scale investor confidence.
Additionally, XRP futures trading on the CME saw a $1.3 million increase in volume last week, showing continued appetite for exposure from professional traders and institutions.
These developments suggest that the market may be entering a new phase where institutional inflows and outperforming ratios could keep XRP bullish longer than previously expected.
What is the short-term outlook for XRP price?
In the short term,
XRP remains bullish
, but only if it can hold key support levels and break past resistance.
Short-term bullish scenario:
Support holds above $2.75, and XRP breaks above $3.16, triggering technical buying.
Momentum continues as ETF demand drives interest.
Price pushes toward $4.50, the 161.8% Fibonacci extension.
Short-term bearish scenario:
XRP fails to close above $3.16 and falls back below $2.75.
Institutional buying slows, and broader crypto market remains uncertain.
Price revisits $2.50 or even lower to $2.24 support zone.
At the moment, the bullish technicals outweigh bearish risks, but caution remains if volume dries up or Bitcoin faces more downward pressure.
How does the long-term XRP forecast look?
Long-term bullish outlook:
The seven-year breakout pattern, first highlighted by CoinGape, remains intact.
If historical trends play out, XRP could climb toward $10 or even $38, though that would require sustained institutional inflows, favorable regulation, and broader crypto adoption.
ETF growth like Teucrium's $284M milestone, and CME volume surges, indicate long-term interest is forming.
Long-term bearish risks:
Legal or regulatory challenges, particularly around Ripple's ongoing SEC issues, could dampen investor sentiment.
Failure to sustain above key macro resistance levels may keep XRP in a long-term range.
If Ethereum or Bitcoin regain dominance and outpace XRP, relative underperformance could return.
Can XRP hit $4.50 soon?
Right now, XRP's price sits just under a key breakout level, and the charts are flashing bullish signals—SMA convergence, ADX strength, and a rising XRP/ETH ratio. The Teucrium ETF's $284M AUM and increased CME volumes show institutional players are clearly interested.
The next major test is whether XRP can close above $3.16. If that happens, the path to $4.50 becomes much more realistic.
But like all crypto assets, XRP's journey will depend on both internal strength and the broader market conditions. Traders and long-term holders alike will be watching closely.
FAQs:
Q1: Why did
XRP price drop
by 3.2% today?
XRP dropped due to profit-taking and broader market weakness after briefly crossing $3.
Q2: What is the current XRP price today?
As of now, XRP is trading around $2.87 after falling below the $2.91 mark.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
36 minutes ago
- Time of India
How should you position yourself in IT and pharma now? Neeraj Dewan answers
Neeraj Dewan , Market Expert suggests a cautious approach to IT stocks. The IT sector's result season is not promising. Investors should await clarity on earnings and US business trends. Holding TCS and Infosys might be wise. Pharma tariffs are creating confusion. Focus on individual pharma stocks. Investors should stay invested in their chosen stocks. Monitor tariff developments closely for potential impacts. After the TCS as well as HCL Technologies Q1 results, it seems like IT will need to be avoided this quarter too? Neeraj Dewan : Yes, definitely the beginning of the result season has not been good for IT. It was on expected lines because we are not expecting good results from IT this quarter and even the immediate outlook is not that clear. So, one should wait to get more clarity; one, what is going to happen on the earnings front and second, what clues we have from the US regarding business going ahead. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 월 1만원으로 저소득 아이들의 한끼 선물하기 굿네이버스 더 알아보기 Undo So, one should really wait and see how it goes. As far as largecap IT is concerned, if TCS, Infosys consolidate in this region and stop correcting, maybe it is not a good idea to sell them at this point. One should hold on to them to get more clarity or start accumulating. A lot of things are happening in the pharma space. There is some stock specific action from Zydus Life, positive news flow coming in for Zydus as well as Biocon for their diabetes drug Kirsty. Other than that, there is some commentary coming in from Trump where he is saying that pharma tariffs could be announced by the end of this month. What is your take on the sector? How should investors position themselves in this sector? Neeraj Dewan: As far as the tariffs are concerned, there are two things. One, Trump has been speaking about pharma tariffs for quite some time. Off and on, he comes out with statements but the market has not reacted too much and stocks have been doing well. Second, there are these country specific deals. There is still no clarity if India will have a country-specific deal. If there will be separate tariffs for all industries, then what is the idea of having a country specific deal? There is a lot of confusion over tariffs as of now. So, I do not think stocks will react too much. For an investor, it would be best to just invest in the stocks we like and stay invested in them as far as pharma is concerned. Pharma has been a stock specific bet and one cannot really invest across because now the stocks are not that cheap. They are quite fairly valued. We will get pockets there. We will get stocks which are doing very well and stock specific moves will come. So, you should stay invested in the ones you are betting on and then see how it goes as far as the tariffs are concerned. Live Events You Might Also Like: Don't peg your expectations from market too high; look for growth stories: Shreyas Devalkar Is there merit in looking at the two-wheeler space right now? Yesterday, the entire pack was fairly charged up. We have seen an early onset of monsoon as well. The distribution so far as well pretty much seems to be on course. Is that going to reflect in the two-wheeler numbers? Neeraj Dewan: Yes, I think so because bigger companies like Hero Motors and Bajaj Auto have come out with some statements. They are going to be aggressive and they are looking at growth going ahead. We have seen that if we have a good monsoon, there is definitely a pickup in demand in the two-wheeler space. Going ahead, since inflation is low, there is excess liquidity in the system, and we are having a good monsoon as well, it will all augur well for the sector. Hero Motor is trading at discount to its long-term averages. At this price, getting into Hero Motor should make sense for a long-term investor. Similarly, in Bajaj Auto, we are yet to see some improvement happening. Let us see the results for this quarter and then we will take a call on Bajaj Auto. Hero Motor definitely as they are quoting 20 times historical and Bajaj Auto is at close to 30 times historical; 12 months trailing are showing attractive valuations. One should consider them for long-term investing. In terms of the stock market, insurance has been a nonstarter barring a few odd moves here and there. How should insurance be looked at? It may be a structural story but the stocks have not performed at all. Neeraj Dewan: You are right, it is a structural story where five-six years back, everyone believed it would be a good value generator. But everyone got invested also. You see long-term portfolios, they are holding on to some good insurance stock. The funds have been holding on to them. But that follow-up big buying is not coming because there is no exceptional gain which comes specifically from life insurance companies. Life insurance companies have been a drag and going ahead, we are looking at 10-12% return. We can still get that kind of return in this sector. But general insurance is one where there is still good scope. There can be growth there and we have seen those companies doing better also. So, if I have to pick one of the two, I will pick general insurance. You Might Also Like: Positive on auto, expect rate cuts to revive PV, two-wheeler sales: Varun Goel
Time of India
38 minutes ago
- Time of India
Dixon's Rs 1,000 crore bet: Ties up with two Chinese firm for key electronics components; gears up for post-PLI era
Dixon Technologies is set to invest Rs 1,000 crore to strengthen its expertise in producing key components such as camera and fingerprint modules, as well as precision mechanical enclosures used in mobile phones, IoT devices, laptops and automobiles. The move is aimed at deepening backward integration and reducing reliance on external suppliers across its manufacturing operations. The company on Tuesday revealed a joint venture with China's Chongqing Yuhai Precision Manufacturing for the production of precision mechanical parts used in mobiles, laptops, Internet of Things (IoT) devices and automobiles. Under the deal, Dixon will hold a 74% stake, keeping the Chinese partner's share within the government's informal 26% cap under the component manufacturing programme. Additionally, Dixon has signed a term sheet to acquire a 51% stake in the India arm of China-based Kunshan Q Tech Microelectronics, which manufactures camera and fingerprint modules. The acquisition, worth Rs 500 crore, will be followed by another Rs 250 crore investment to scale up production capacity, under the Centre's Rs 22,919 crore Electronics Component Manufacturing Scheme. 'Acquiring majority stake in Qtech India is a major step forward in Dixon's journey foraying into development and production of camera modules and fingerprint recognition modules across mobile handsets, IoT devices and automotive applications thereby strengthening backward integration plans of the Company' Atul Lall, managing director of Dixon Technologies told ET. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Esta nueva alarma con cámara es casi regalada en Rivadavia (ver precio) Verisure Más información Undo 'This JV with Chongqing will focus on manufacturing precision mechanical & metal parts & components for a wide range of applications including laptops, mobiles, IoT, automotive which is a significant step in our effort towards localisation of key components, deepening backward integration in Dixon value chain' Lall was quoted as saying. Dixon's broader ambition is to reduce its dependence on low-margin assembly work and secure long-term margins through tech-led manufacturing. The investment also reflects a growing trend among Indian players to form strategic tie-ups with global tech suppliers as the PLI scheme nears its end. Currently, Kunshan Q Tech's Indian operations produce about 4 million modules monthly, largely catering to Android handset makers. The facility will now be ramped up to support Dixon's own assembly lines. This is Dixon's third such partnership to boost its component portfolio. The company earlier teamed up with China's HKC to produce display modules, and with Taiwan's Inventec to manufacture PCs and laptops. It also partners with smartphone majors like Vivo, Motorola and Transsion for long-term production contracts. Dixon remains one of the few Indian firms to qualify for incentives under the PLI scheme for smartphone manufacturing, which is scheduled to run till 2026. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Time of India
an hour ago
- Time of India
What is moonlighting? Soham Parekh's blunt statement 'I love what I do' sparks fresh outrage online
Soham Parekh, the Indian tech professional who became a lightning rod in the global startup ecosystem for simultaneously working full-time jobs at multiple companies, is once again in the public spotlight. Known for triggering widespread discussions around moonlighting ethics, work-life balance, and hustle culture, Parekh now claims that his life has remained 'unchanged' following the controversy. In a recent post on social media platform X (formerly Twitter), he offered a candid glimpse into his current state of mind, sparking renewed debate across tech circles. His remarks reflect deeper concerns about modern professional life, burnout, and ethical boundaries in remote work. Who is Soham Parekh and why was he controversial Soham Parekh, a Mumbai-based software engineer, was publicly accused in 2023 of secretly holding full-time roles at multiple US-based startups. The accusations were led by the co-founder of Playground AI and former CEO of Mixpanel Suhail Doshi who alleged that Parekh was drawing salaries from as many as three to four companies simultaneously, some of which were Y Combinator-backed ventures, including Dynamo AI and Synthesia. Parekh later acknowledged these claims, stating in an interview that he was driven by financial distress, which compelled him to accept overlapping roles. He also revealed that he worked up to 140 hours per week, navigating tight deadlines, multiple meetings, and high-performance expectations. While some in the tech community were impressed by his time management and technical capabilities, the majority criticized his actions as unethical, especially because he failed to disclose his dual employment to employers. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like An engineer reveals: One simple trick to get internet without a subscription Techno Mag Learn More Undo 'I Love What I Do': Soham Parekh's latest remarks In his latest public post, Soham Parekh shared a screenshot of a message exchange where someone asked how he manages to work so much. He replied bluntly, 'I love what I do. Lol. I don't have anything else to do.' He added in a follow-up caption, 'My life hasn't changed one bit.' Though casual in tone, the statement quickly went viral, drawing strong reactions. The message struck a chord with many professionals navigating the high-pressure environments of startups, where identity and productivity often overlap. Parekh's comments reignited discussion around the emotional toll of hustle culture, especially in sectors where overworking is normalized and sometimes even glorified. What is the moonlighting debate The moonlighting debate refers to the growing controversy around professionals taking on multiple jobs often simultaneously without informing their primary employer. While moonlighting traditionally meant holding a second job outside regular working hours, the rise of remote work and gig culture has blurred these boundaries, especially in tech and startup industries. At the center of the debate are ethical, legal, and productivity concerns. Some companies view undisclosed secondary employment as a breach of trust or a conflict of interest, especially when employees hold multiple full-time roles. Others, however, argue that moonlighting is a personal right—especially in economies where one job may not be financially sufficient. Key issues in the moonlighting debate The moonlighting debate stems from a complex interplay of transparency, contractual obligations, performance expectations, economic realities, and evolving workplace norms. Employers emphasize transparency and trust, arguing that undisclosed secondary jobs raise concerns about divided attention, compromised performance, and potential misuse of confidential information. Employment contracts often explicitly prohibit outside work that might conflict with the company's interests, further complicating the issue. Critics of moonlighting warn that juggling multiple demanding roles can lead to burnout and reduced productivity, ultimately affecting team outcomes. However, proponents highlight economic necessity, pointing to inflation and stagnant wages as reasons why professionals seek additional income. The rise of remote work post-COVID has only intensified this dynamic, enabling individuals to pursue side gigs or full-time dual roles with less oversight, blurring the lines between flexibility and ethical responsibility. Social media reacts to recent Soham Parekh's remarks The public response to Parekh's remarks was mixed and emotionally charged. Many users on social media platforms expressed concern, calling the statement a 'cry for help,' while others found it relatable. Some viewed Parekh's work ethic as admirable, even inspirational, in a results-driven industry where multi-tasking is often seen as a valuable skill. However, others interpreted his message as a symptom of a larger burnout epidemic. They raised questions about mental health, personal fulfillment, and the cost of tying self-worth solely to productivity. The debate also reflected generational shifts in how work and life priorities are viewed—particularly among millennial and Gen Z tech professionals. Ethical dilemma surrounding Soham Parekh's undisclosed moonlighting At the heart of the controversy lies the question of ethics. Moonlighting, particularly without employer consent, presents serious implications in terms of transparency, trust, and data security. While side gigs are common in the tech industry, especially among freelancers and consultants, holding multiple full-time roles simultaneously as Soham Parekh did creates an undeniable conflict of interest. His defenders argue that the industry itself is partly to blame. Many startups demand long hours, deliverables at breakneck speed, and loyalty that often exceeds what compensation justifies. In such an environment, Parekh's actions have been seen by some as a form of survival, albeit a controversial one. However, critics argue that regardless of intent, undisclosed dual employment undermines accountability and could lead to compromised performance, divided attention, and violations of employment contracts. Also Read | Anand Mahindra shares one powerful lesson from 44 years of leadership to help you overcome stress AI Masterclass for Students. Upskill Young Ones Today!– Join Now
